All In Biotech

Drug Trial Radar · NCT00594425

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne

Last checked: Nov 20, 2026Latest source record: Aug 8, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

150

Actual

Start

Feb 2007

Primary completion

Jul 2008

Study completion Sep 2008

Sponsor

Lead sponsor
PhotocureIndustry
Sponsor type
Industry
First posted
Jan 15, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 15 years, up to 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This multicenter study will be divided into 2 phases. The first phase will be an open label, dose-escalation phase, while the second will be a blinded, randomized, vehicle-controlled, parallel-group, dose-response phase. The second phase will only start if the first phase succeeds in establishing well tolerated dose(s). Patients with moderate to severe acne vulgaris in the face will be included.The results from part 2 has been presented in the result section.

Conditions

  • Acne Vulgaris

Interventions

  • Methyl aminolevulinate (MAL) PDTDrug

    Cream application followed by illumination with red light

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Success, Defined as Improvement of at Least 2 Grades From Baseline According to the IGA Scale Based on Facial AssessmentTime frame: 12 weeks after last treatment
  2. Change in Facial Inflammatory (Nodules, Papules, and Pustules) Lesion CountsTime frame: 12 weeks after last treatment
  3. Change in Facial Inflammatory (Nodules, Papules, and Pustules) Lesion Counts From BaselineTime frame: 12 weeks

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Therapeutics Clinical Research

    San Diego, California

  • Solano Clinical Research

    Vallejo, California

  • DuPage Medical Group

    Naperville, Illinois

  • Michigan Center for Research Corp

    Clinton Twp, Michigan

  • Academic Dermatology Associates

    Albuquerque, New Mexico

  • Dermatology Associates of Rochester

    Rochester, New York

  • Central Sooner Research

    Norman, Oklahoma

  • Oregon Dermatology and Research Center

    Portland, Oregon

  • Dermatology Treatment & Research

    Dallas, Texas

  • Suzanne Bruce and Associates, PA

    Houston, Texas

  • The Dermatology Clinical Research Center of San Antonio

    San Antonio, Texas

  • Dermatology Research Center, Inc.

    Salt Lake City, Utah

  • The Education & Research Foundation, Inc.

    Lynchburg, Virginia

  • Virginia Clinical Research, Inc.

    Norfolk, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.